Clinical Trials Browser

Phase 3 × trastuzumab deruxtecan × CNS × Clear all

NCT04739761 2026-02-11

DESTINY-B12

Phase 3 Active not recruiting

506 enrolled 27 charts

Brain Neoplasms, Breast Neoplasms